ADC Therapeutics SA
DOSAGE REGIMES FOR THE ADMINISTRATION OF AN ANTI-CD25 ADC

Abstract:

The present disclosure relates to novel dosage regimes for the treatment of pathological conditions, such as cancer, with Antibody Drug Conjugates (ADCs). In particular, the present disclosure relates to novel dosage regimes for the administration of ADCs which bind to CD25 (CD25-ADCS). ##STR00001##